Budau, Laura
Wilhelm, Christian
Moll, Roland
Jäkel, Jörg
Hirt, Carsten
Dölken, Gottfried
Maschmeyer, Georg
Neubauer, Ellen
Strauch, Konstantin
Burchert, Andreas
Herold, Michael
Neubauer, Andreas https://orcid.org/0000-0002-7606-8760
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (KFO210)
José Carreras Leukämie-Stiftung (AH06-01)
Article History
Received: 31 January 2019
Accepted: 22 June 2019
First Online: 4 July 2019
Compliance with ethical standards
:
: Georg Maschmeyer reports personal fees from Celgene, personal fees from Novartis, personal fees from Bristol-Myers Squibb, personal fees from Janssen-Cilag, not related to the current paper. Andreas Neubauer has received honoraria from Medupdate GmbH, not related to the current paper.